Skip to main navigation Skip to search Skip to main content

Inhibitors of α-synuclein oligomerization and toxicity: A future therapeutic strategy for Parkinson's disease and related disorders

  • United Arab Emirates University
  • Queen's University Belfast

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Inhibitors of α-synuclein oligomerization and toxicity: A future therapeutic strategy for Parkinson's disease and related disorders'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Neuroscience

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science